Insulin-mediated venodilation is impaired in patients with high cholesterol

Hypertension

Volumn 31, Issue 6, 1998, Pages 1266-1271

  Sung, Bong Hee ^a,b   Ching, Marilou ^a   Izzo Jr , Joseph ^a   Dandona, Paresh ^a   Wilson, Michael F ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b MILLARD FILLMORE HOSPITAL   (United States)

Author keywords

Endothelium; Hypercholesterolemia; Insulin; Norepinephrine; Vasoreactivity

Indexed keywords

CHOLESTEROL; CYCLIC GMP; INSULIN; MEVINOLIN; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR ENDOTHELIUM; VEIN DIAMETER;

EID: 0031811119     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.6.1266     Document Type: Article

References (29)

1. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in coronary microcirculation of atherosclerotic primates. Circulation. 1990;81:1586-1593.
2. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
3. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo. Hypertension. 1991;18(suppl II):II-90-II-99.
4. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation. 1991;84:1273-1278.
5. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
6. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res. 1989;64:900-914.
7. Merkel LA, Rivera LM, Bilder GE, Perrone MH. Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterol. Circ Res. 1990;67:550-555.
8. Casino RC, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
9. Sung BH, Izzo JL Jr, Wilson MF. Effects of cholesterol reduction on blood pressure response to mental stress in patients with high cholesterol. Am J Hypertens. 1997;10:552-559.
10. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-498.
11. Drexler H, Zeiher AM, Wollschlager T, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation. 1989; 79:287-291.
12. Grover A, Padgington C, Wilson MF, Sung BH, Izzo JL Jr, Dandona P. Insulin attenuates norepinephrine-induced venoconstriction: an ultrasonographic study. Hypertension. 1995;25:779-784.
13. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron A. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94: 1172-1179.
14. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effect in humans. J Clin Invest. 1994;94:2511-2515.
15. Kahn AM, Siedel CL, Allen JC, O'Neal RG, Shelat H, Song T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension. 1993;22:735-742.
16. Creager MA, Liang CS, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther. 1985;235:709-714.
17. Lembo G, Rendina V, Iaccarino G, Lamenza F, Volpe M, Trimarco B. Insulin reduces forearm vasoconstriction evoked by reflex sympathetic activation in healthy humans. Hypertension. 1993;21:1015-1019.
18. Robinson BF. Assessment of the effects of drugs on the venous system in man. Br J Clin Pharmacol. 1978;6:381-386.
19. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res. 1986;58:552-564.
20. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
21. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet. 1992;340:1430-1432.
22. Wood EJ, Eckstein JW. A tandem forearm plethysmography for study of acute responses of the peripheral veins of man: the effect of environment and local temperature change and the effect of pooling blood in the extremities. J Clin Invest. 1958;37:41-50.
23. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol. 1981;11:237-243.
24. Coupar IM. The effect of isoprenaline on adrenoreceptors in saphenous vein. Br J Pharmacol. 1970;13:465-475.
25. Alradi AO, Carruthers SG. Evaluation and application of the linear variable differential transformer technique for assessment of human dorsal hand vein a-receptor activity. Clin Pharmacol Ther. 1985;38: 495-502.
26. Vincent J, Blaschke TF, Hoffman BB. Vascular reactivity to phenylephrine and angiotensin II: comparison of direct venous and systemic vascular responses. Clin Pharmacol Ther. 1992;51:68-75.
27. Collier JG, Nachev C, Robinson BF. Effect of catecholamines and other vasoactive substances on superficial hand-veins in man. Clin Sci. 1972; 43:455-467.
28. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332:481-487.
29. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.